Jay N Schapira Md Medical Research Foundation Inc is located in Los Angeles, CA. The organization was established in 1986. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 11/2021, Jay N Schapira MD Medical Research Foundation Inc employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Jay N Schapira MD Medical Research Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 11/2021, Jay N Schapira MD Medical Research Foundation Inc generated $389.4k in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 21.4% each year . All expenses for the organization totaled $435.0k during the year ending 11/2021. While expenses have increased by 1.6% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
RESEARCH IN CARDIAC DISEASE IN ORDER TO UNDERSTAND THE CAUSE AND DEVELOP TREATMENT STRATEGIES IN
Describe the Organization's Program Activity:
Part 3 - Line 4a
PHASE I - INVESTIGATING THE CELLULAR ORIGIN OF RESIDENT CARDIAC STEM CELLS (CARDIOSPHERES) AND CLINICALLY ISOLATING THEM AND PREPARING TO DETERMINE THEIR BIOLOGY SO THAT THEY MIGHT BE INFUSED INTO HEART ATTACK VICTIMS.PHASE II - INVESTIGATING INTO THE SIGNIFICANCE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN PATIENTS UNDERGOING PRIMARY CORONARY INTERVENTIONS WITH DRUG-ELUTING STENTS AND COLLECTING DATA ON ENDOTHELIAL PROGENITOR CELLS AT THE TIME OF THESE PROCEDURES.PHASE III - CONTINUING THE RANDOMIZED EVALUATION OF INTRACORONARY TRANSPLANTATION OF BONE MARROW STEM CELLS IN ACUTE MYOCARDIAL INFARCTION CHARACTERIZED BY ST SEGMENT ELEVATION AND TRANSMURAL INFARCTS. INVESTIGATION OF MICROVASCULAR ISCHEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ASCERTAIN IMPROVED, ACCURATE DIAGNOSTIC PROCEDURES.TREATMENT OF CORONARY ARTERY DISEASE, ESPECIALLY REVASCULARIZATION OF THE LEFT MAIN CORONARY ARTERY (PERCUTANEOUS CORONARY INTERVENTION IN UNPROTECTED LEFT MAIN DISEASE).EVAULATION AND TREATMENT OF CHEST PAIN CAUSED BY MICROVASCULAR ISCHEMIA FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PUBLISH RESULTS.EDUCATIONAL PUBLICATION FOR MULTIFACET TREATMENT OF ATRIAL FIBRILLATION BY MEDICATION AND DEVICE.CLASSIFICATION AND CHARACTERIZATION OF COMPLEX CORONARY ARTERY STENOSIS MORPHOLOGY BY CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY.DUE TO THE RECOGNITION OF DR. JAY N SCHAPIRA'S (THE PRESIDENT OF THE FOUNDATION) ACCOMPLISHMENTS AND RESEARCH, HE WAS APPOINTED A CLINICAL PROFESSOR OF MEDICINE AT THE CEDARS-SINAI HEART INSTITUTE IN MAY 2014.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jay N Schapira MD President/director | OfficerTrustee | 15 | $222,000 |
Phyllis Schapira Secretary/director | OfficerTrustee | 0.3 | $0 |
Robert Kass MD Director | Trustee | 0.3 | $0 |
Ronald Fisk MD Director | Trustee | 0.3 | $0 |
Bernard Bubman Director | Trustee | 0.3 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $60,500 |
All other contributions, gifts, grants, and similar amounts not included above | $61,620 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $122,120 |
Total Program Service Revenue | $0 |
Investment income | $26,844 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $240,467 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $389,431 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $222,000 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $120,853 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $15,864 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $11,876 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $15,303 |
Fees for services: Other | $1,468 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $2 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $434,990 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $17,620 |
Savings and temporary cash investments | $294,864 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $800,978 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,113,462 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $530,568 |
Total liabilities | $530,568 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $582,894 |
Total liabilities and net assets/fund balances | $1,113,462 |
Over the last fiscal year, we have identified 1 grants that Jay N Schapira Md Medical Research Foundation Inc has recieved totaling $10,000.
Awarding Organization | Amount |
---|---|
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $10,000 |
Organization Name | Assets | Revenue |
---|---|---|
Chan Zuckerberg Biohub Inc San Francisco, CA | $338,316,919 | $10,314,755 |
Critical Path Institute Tucson, AZ | $19,962,086 | $31,176,116 |
Medicines360 San Francisco, CA | $84,365,229 | $12,024,199 |
Research Corporation Tucson, AZ | $242,008,144 | $26,138,153 |
Southwest Autism Research And Resource Center Phoenix, AZ | $18,925,029 | $16,667,407 |
Conard House Inc San Francisco, CA | $5,907,710 | $14,988,369 |
Hopelab Foundation Inc San Francisco, CA | $32,085,472 | $14,961,821 |
Multidisciplinary Association For Psychedelic Studies San Jose, CA | $92,188,866 | $23,580,425 |
Glenn Foundation For Medical Research Inc Phoenix, AZ | $192,520,690 | $23,653,368 |
Hmsa Foundation Honolulu, HI | $18,488,325 | $337,265 |
Larry L Hillblom Foundation Inc Petaluma, CA | $157,022,260 | $9,255,919 |
Arastradero Research Institute Palo Alto, CA | $86,734,431 | $15,446,292 |